TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Martin Dahl Medtech AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
921
|
1,434
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
52
|
1,197
|
-1 |
| EBITDA |
44
|
1,197
|
-1 |
| Total assets |
1,122
|
1,278
|
1 |
| Current assets |
1,092
|
1,278
|
1 |
| Current liabilities |
617
|
271
|
19 |
| Equity capital |
489
|
946
|
-18 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.6%
|
74.0%
|
-1800% |
| Turnover per employee |
921
|
1,434 | |
| Profit as a percentage of turnover |
5.6%
|
83.5% | |
| Return on assets (ROA) |
4.6%
|
93.7%
|
-100% |
| Current ratio |
177.0%
|
471.6%
|
5.3% |
| Return on equity (ROE) |
10.6%
|
126.5%
|
5.6% |
| Change turnover |
-539
|
1,434
|
0 |
| Change turnover % | -37% | ||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.